SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-013417
Filing Date
2024-02-13
Accepted
2024-02-13 17:05:49
Documents
1
Group Members
VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea193544-13ga1vivo_clene.htm SC 13G/A 94528
  Complete submission text file 0001213900-24-013417.txt   96184
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Subject) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91949 | Film No.: 24628468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity Fund Holdings, L.P. (Filed by) CIK: 0001930214 (see all company filings)

IRS No.: 873802421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A